Abstract:〔Abstract〕 Objective To investigate the clinical significance of serum lactate dehydrogenase (LDH), folate (SFA), and thymidine kinase 1 (TK1) in patients with myelodysplastic syndrome (MDS). Methods 80 MDS patients admitted to Fuzhou First Hospital from March 2020 to March 2023 were retrospectively selected as the observation group, and 80 healthy individuals who underwent physical examinations at Fuzhou First Hospital during the same period were selected as the control group. LDH, SFA, and TK1 levels were compared between the observation group and the control group; In addition, according to the severity of disease in the observation group, the patients were divided into low-risk group (25 cases), medium-risk group (26 cases) and high-risk group (29 cases). The levels of serum LDH, SFA, and TK1 in the three groups will be compared, and the Spearman correlation coefficient will be used to analyze the correlation between LDH, SFA, TK1 and disease severity in MDS patients. Results The levels of serum LDH and TK1 in the observation group were higher than those in the control group, while SFA was lower than that in the control group; The LDH and TK1 levels in the medium and high-risk groups were higher than those in the low-risk group, while the SFA levels were lower than those in the low-risk group. In addition, the LDH and TK1 levels were higher and the SFA levels were lower in the high-risk group, and the differences were statistically significant (P < 0.05); According to Spearman correlation analysis, the severity of MDS patients is negatively correlated with SFA levels (ρ = – 0.893, P < 0.001), at LDH level (ρ = 0.952, P < 0.001), TK1 level (ρ = 0.926, P < 0.001) shows a positive correlation. Conclusion The levels of LDH, SFA, and TK1 are closely related to the severity of MDS, and can provide reference for the diagnosis and evaluation of clinical MDS.